Patents
Sitemap › C12 - Biochemistry; Beer; Spirits; Wine; Vinegar; Microbiology; Enzymology; Mutation or genetic engineering › C12N - Micro-organisms or enzymes; Compositions thereof; Propagating, preserving, or maintaining micro-organisms; Mutation or genetic engineering; Culture media › C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210)
10/2009
10/22/2009WO2009128399A1 Oligonucleotide probe and microarray for determination of genome type of bk virus
10/22/2009WO2009128272A1 Expression vector
10/22/2009WO2009128077A1 Stable cell binding chimeric peptides
10/22/2009WO2009127897A1 Oryza sativa protein kinase gene oscipk 15 and the use thereof in improving salt stress tolerance in plants
10/22/2009WO2009127766A1 System for the expression of peptides on the bacterial surface
10/22/2009WO2009127754A1 USE OF eNOS INHIBITORS IN NERVOUS REGENERATION
10/22/2009WO2009127729A1 Polypeptides having ferulic acid esterase activity and polynucleotides encoding same
10/22/2009WO2009127680A1 Pharmaceutical composition comprising anti pcsk9 oligomers
10/22/2009WO2009127671A1 Plants having enhanced yield-related traits and a method for making the same
10/22/2009WO2009127443A2 Transcription factors involved in salt stress in plants
10/22/2009WO2009127441A2 Transcription factors involved in drought stress in plants
10/22/2009WO2009127350A1 Method for optimized isolation of rna from fixed tissue
10/22/2009WO2009127230A1 MODIFIED (m)RNA FOR SUPPRESSING OR AVOIDING AN IMMUNOSTIMULATORY RESPONSE AND IMMUNOSUPPRESSIVE COMPOSITION
10/22/2009WO2009127154A1 A newly identified human rhinovirus of hrv-c and methods and kits for detecting hrv-cs
10/22/2009WO2009127140A1 7p peptide and its derivant, the use thereof
10/22/2009WO2009127081A1 A newly identified human rhinovirus of hrv-c and methods and kits for detecting hrv-cs
10/22/2009WO2009127060A1 Novel lipid formulations for nucleic acid delivery
10/22/2009WO2009127050A1 Functional enhancement of yeast to minimize production of ethyl carbamate via modified transporter expression
10/22/2009WO2009117555A8 Floral dip method for transformation of camelina
10/22/2009WO2009108891A3 Modified poloxamers for gene expression and associated methods
10/22/2009WO2009108774A3 Use of synthetic scaffolds for the production of biosynthetic pathway products
10/22/2009WO2009107159A3 System for inducible gene expression in chlamydomonas
10/22/2009WO2009106773A3 Transgenic mice for the c gamma gene human class-g immunoglobulins
10/22/2009WO2009105572A3 Antisense modulation of amyloid beta protein expression
10/22/2009WO2009102357A3 Hiv-1 envelope glycoprotein oligomer and methods of use
10/22/2009WO2009100351A8 Delivery of rnai constructs to oligodendrocytes
10/22/2009WO2009095226A3 NUCLEIC ACIDS COMPRISING FORMULA (NuGlXmGnNv)a AND DERIVATIVES THEREOF AS AN IMMUNOSTIMULATING AGENTS /ADJUVANTS
10/22/2009WO2009092772A3 Plants having enhanced yield-related traits and a method for making the same
10/22/2009WO2009092009A9 Modulating light response pathways in plants
10/22/2009WO2009088405A3 System and method utilizing the expression of tlk1b protein in normal human cells to protect against dna damage
10/22/2009WO2009073905A3 Method for increasing immunoreactivity
10/22/2009WO2009070038A3 Polynucleotides and methods for improving plants
10/22/2009WO2009045627A3 Xylanases, nucleic acids encoding them and methods for making and using them
10/22/2009WO2009045581A3 Bacteriophage with enhanced lytic activity
10/22/2009WO2009041932A3 Enzymes involved in triterpene synthesis
10/22/2009WO2008132729A3 Promoters exhibiting endothelial cell specificity and methods of using same for regulation of angiogenesis
10/22/2009WO2002044329A9 Receptor-mediated uptake of peptides that bind the human transferrin receptor
10/22/2009WO2001000878A9 A novel vascular endothelial growth factor family member and uses thereof
10/22/2009US20090265817 Herbicide resistant transformed sugar beet that is detectable by the specific primers; glyphosate resistant sugar beet plant
10/22/2009US20090265816 Isolated nucleic acid molecules from the genome of citrus leprosis virus and uses thereof
10/22/2009US20090265815 Sequence-determined DNA fragments and corresponding polypeptides encoded therapy
10/22/2009US20090265814 Plant transformation with in vivo assembly of a sequence of interest
10/22/2009US20090265813 Stress tolerance in plants
10/22/2009US20090265812 Plant Gene Promoter and its Use
10/22/2009US20090265811 Maize plants with reduced gene silencing
10/22/2009US20090265810 Arabidopsis genes encoding proteins involved in sugar and lipid metabolism and methods of use
10/22/2009US20090265809 Modified Cry3A Toxins and Nucleic Acid Sequences Coding Therefor
10/22/2009US20090265808 P15 hairpin constructs and use
10/22/2009US20090265807 transcription factor polynucleotides; transgenic plants having increased soluble solids, lycopene, and improved plant volume or yield, increased anthocyanin in leaves, seedling vigor
10/22/2009US20090265806 Pericarp-preferred regulatory element
10/22/2009US20090265805 Glutamate receptors in nutrient sensing, metabolism, Growth and Development
10/22/2009US20090265804 Nucleotide sequences encoding enzymes in biosynthesis of dihydroartemisinic acid
10/22/2009US20090265802 Wheat variety 25r62
10/22/2009US20090265798 Desaturase genes and uses thereof
10/22/2009US20090265797 Novel Anti-IGF-IR Antibodies and Uses Thereof
10/22/2009US20090265796 DNA segment that confers increased episomal stability, persistence or abundance of the isolated DNA molecule in a host cell; genetic engineering
10/22/2009US20090265795 Methods of Inhibiting Multiple Cytochrome P450 Genes with siRNA
10/22/2009US20090264666 Delta-8 desaturase and its use in making polyunsaturated fatty acids
10/22/2009US20090264636 Conjugates and compositions for cellular delivery
10/22/2009US20090264625 Method for recombinant microorganism expression and isolation of collagen-like polypeptides
10/22/2009US20090264624 Human cytokine receptor
10/22/2009US20090264618 Compounds With a Branched Linker
10/22/2009US20090264616 Cyclodipeptide Synthetases and Their Use for Synthesis of Cyclo(Leu-Leu) Cyclodipeptide
10/22/2009US20090264515 Polynucleotide therapy
10/22/2009US20090264513 Expression vector
10/22/2009US20090264511 Compositions and methods for inhibiting expression of factor vii gene
10/22/2009US20090264510 Double helical oligonucleotides interfering with mRNA used as effective anticancer agents
10/22/2009US20090264509 Adenoviral vector-based foot-and-mouth disease vaccine
10/22/2009US20090264506 Delivery of polynucleotide agents to the central nervous system
10/22/2009US20090264505 Methods and compositions for rnai mediated inhibition of gene expression in mammals
10/22/2009US20090264501 Methods and Compositions to Inhibit P2x7 Receptor Expression
10/22/2009US20090264381 Nucleic acid and corresponding protein entitled 151p3d4 useful in treatment and detection of cancer
10/22/2009US20090264370 Polypeptides homologous to vegf and bmp1
10/22/2009US20090264364 Genes implicated in the regulation of angiogenesis, pharmaceutical preparations containing them and their applications
10/22/2009US20090264361 Identification of a family of secreted proteins in vascular endothelium
10/22/2009US20090264360 Cloning and expression of gonadotropin-releasing hormone (GnRH) receptors
10/22/2009US20090264358 Vegf receptor fusion proteins, their pharmaceutical compositions and therapeutic applications for the eye diseases
10/22/2009US20090264356 Adenovirus 36 E4 orf 1 Gene and Protein and Their Uses
10/22/2009US20090264353 Splice Switching Oligomers for TNF Superfamily Receptors and their Use in Treatment of Disease
10/22/2009US20090264349 CD30 Ligand
10/22/2009US20090264318 Analyzing Blood Type with Identification of Patient by Genotyping
10/22/2009US20090264313 Oligonucleotide library encoding randomised peptides
10/22/2009US20090264312 Method for removing desired chromosome and tailor-made medical treatment utilizing the same
10/22/2009US20090264309 Methods for Screening for Compounds that Modulate Insulin Promoter Activity
10/22/2009US20090264305 Polynucleotide Marker Genes and their Expression, for Diagnosis of Endotoxemia
10/22/2009US20090264304 Normalized nucleic acid libraries and methods of production thereof
10/22/2009US20090264303 Polypeptides having a functional domain of interest and methods of identifying and using same
10/22/2009US20090264301 Methods utilizing differential splicing events in blood cells for the detection of pathological events
10/22/2009US20090263902 Method for regulating agrobacterium-mediated transformation
10/22/2009US20090263900 Linear donor constructs for targeted integration
10/22/2009US20090263898 Artificial chromosomes, uses thereof and methods for preparing artificial chromosomes
10/22/2009US20090263895 Cell line for producing a non-retroviral vector
10/22/2009US20090263888 Koji mold-origin phospholipase a2
10/22/2009US20090263886 Farnesyl dibenzodiazepinone and processes for its production
10/22/2009US20090263883 Recombinant Parainfluenza Virus Expression Systems And Vaccines Comprising Heterologous Antigens Derived From Respiratory Syncytial Virus
10/22/2009US20090263880 Mutant luciferase
10/22/2009US20090263875 Methods of generating protein variants with altered function
10/22/2009US20090263874 L-glutamic acid-producing bacterium and method for producing l-glutamic acid
10/22/2009US20090263873 Linear vectors, host cells and cloning methods
10/22/2009US20090263872 Methods and compositions for preventing bias in amplification and sequencing reactions
1 ... 1123 1124 1125 1126 1127 1128 1129 1130 1131 1132 1133 1134 1135 1136 1137 1138 1139 1140 1141 1142 1143 ... 4023